Synmosa Biopharma Statistics

Total Valuation

TPEX:4114 has a market cap or net worth of TWD 16.15 billion. The enterprise value is 18.05 billion.

Market Cap	16.15B
Enterprise Value	18.05B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Jul 11, 2025

Share Statistics

TPEX:4114 has 501.47 million shares outstanding. The number of shares has increased by 5.14% in one year.

Current Share Class	501.47M
Shares Outstanding	501.47M
Shares Change (YoY)	+5.14%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	4.53%
Float	397.31M

Valuation Ratios

The trailing PE ratio is 20.39.

PE Ratio	20.39
Forward PE	n/a
PS Ratio	2.64
PB Ratio	1.62
P/TBV Ratio	1.97
P/FCF Ratio	68.77
P/OCF Ratio	34.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.44, with an EV/FCF ratio of 76.87.

EV / Earnings	23.44
EV / Sales	2.95
EV / EBITDA	16.44
EV / EBIT	23.61
EV / FCF	76.87

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.28.

Current Ratio	2.45
Quick Ratio	1.52
Debt / Equity	0.28
Debt / EBITDA	2.50
Debt / FCF	11.96
Interest Coverage	13.18

Financial Efficiency

Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 4.17%.

Return on Equity (ROE)	6.03%
Return on Assets (ROA)	3.76%
Return on Invested Capital (ROIC)	4.17%
Return on Capital Employed (ROCE)	6.76%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.47
Inventory Turnover	1.75

Taxes

In the past 12 months, TPEX:4114 has paid 191.05 million in taxes.

Income Tax	191.05M
Effective Tax Rate	25.75%

Stock Price Statistics

The stock price has increased by +3.40% in the last 52 weeks. The beta is -0.05, so TPEX:4114's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+3.40%
50-Day Moving Average	33.23
200-Day Moving Average	32.68
Relative Strength Index (RSI)	43.45
Average Volume (20 Days)	808,484

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4114 had revenue of TWD 6.11 billion and earned 769.95 million in profits. Earnings per share was 1.58.

Revenue	6.11B
Gross Profit	2.65B
Operating Income	789.56M
Pretax Income	742.03M
Net Income	769.95M
EBITDA	1.12B
EBIT	789.56M
Earnings Per Share (EPS)	1.58

Full Income Statement

Balance Sheet

The company has 2.20 billion in cash and 2.81 billion in debt, giving a net cash position of -605.94 million or -1.21 per share.

Cash & Cash Equivalents	2.20B
Total Debt	2.81B
Net Cash	-605.94M
Net Cash Per Share	-1.21
Equity (Book Value)	9.95B
Book Value Per Share	17.26
Working Capital	3.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 473.51 million and capital expenditures -238.73 million, giving a free cash flow of 234.79 million.

Operating Cash Flow	473.51M
Capital Expenditures	-238.73M
Free Cash Flow	234.79M
FCF Per Share	0.47

Full Cash Flow Statement

Margins

Gross margin is 43.41%, with operating and profit margins of 12.93% and 12.60%.

Gross Margin	43.41%
Operating Margin	12.93%
Pretax Margin	12.15%
Profit Margin	12.60%
EBITDA Margin	18.37%
EBIT Margin	12.93%
FCF Margin	3.84%

Dividends & Yields

This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 1.69%.

Dividend Per Share	0.55
Dividend Yield	1.69%
Dividend Growth (YoY)	9.82%
Years of Dividend Growth	4
Payout Ratio	35.41%
Buyback Yield	-5.14%
Shareholder Yield	-3.45%
Earnings Yield	4.77%
FCF Yield	1.45%

Dividend Details

Stock Splits

The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.099848595.

Last Split Date	Jul 11, 2025
Split Type	Forward
Split Ratio	1.099848595

Scores

TPEX:4114 has an Altman Z-Score of 3.29 and a Piotroski F-Score of 7.

Altman Z-Score	3.29
Piotroski F-Score	7